- Home
- GNLX vs CHSCO Comparison
GNLX vs CHSCO Comparison
Compare GNLX & CHSCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GNLX
- CHSCO
- Stock Information
- Founded
- GNLX 2001
- CHSCO N/A
- Country
- GNLX United States
- CHSCO United States
- Employees
- GNLX N/A
- CHSCO N/A
- Industry
- GNLX Biotechnology: Pharmaceutical Preparations
- CHSCO Farming/Seeds/Milling
- Sector
- GNLX Health Care
- CHSCO Industrials
- Exchange
- GNLX Nasdaq
- CHSCO Nasdaq
- Market Cap
- GNLX 112.8M
- CHSCO N/A
- IPO Year
- GNLX 2023
- CHSCO N/A
- Fundamental
- Price
- GNLX $3.09
- CHSCO $26.25
- Analyst Decision
- GNLX Strong Buy
- CHSCO
- Analyst Count
- GNLX 4
- CHSCO 0
- Target Price
- GNLX $17.75
- CHSCO N/A
- AVG Volume (30 Days)
- GNLX 137.5K
- CHSCO N/A
- Earning Date
- GNLX 08-13-2025
- CHSCO N/A
- Dividend Yield
- GNLX N/A
- CHSCO N/A
- EPS Growth
- GNLX N/A
- CHSCO N/A
- EPS
- GNLX N/A
- CHSCO N/A
- Revenue
- GNLX N/A
- CHSCO N/A
- Revenue This Year
- GNLX N/A
- CHSCO N/A
- Revenue Next Year
- GNLX N/A
- CHSCO N/A
- P/E Ratio
- GNLX N/A
- CHSCO N/A
- Revenue Growth
- GNLX N/A
- CHSCO N/A
- 52 Week Low
- GNLX $1.60
- CHSCO N/A
- 52 Week High
- GNLX $5.89
- CHSCO N/A
- Technical
- Relative Strength Index (RSI)
- GNLX 56.10
- CHSCO 44.43
- Support Level
- GNLX $2.75
- CHSCO $25.82
- Resistance Level
- GNLX $3.17
- CHSCO $26.39
- Average True Range (ATR)
- GNLX 0.24
- CHSCO 0.20
- MACD
- GNLX -0.00
- CHSCO -0.04
- Stochastic Oscillator
- GNLX 56.94
- CHSCO 48.86
About GNLX Genelux Corporation
Genelux Corp is a clinical-stage biopharmaceutical company. The company focuses on developing next-generation oncolytic viral immunotherapies for patients suffering from aggressive or difficult-to-treat solid tumor types. Its pipeline products include Olvi-Vec (olvimulogene nanivacirepvec), Lung, and Pancreatic Cancer.
About CHSCO CHS Inc. Class B Cumulative Redeemable Preferred Stock
CHS Inc is an integrated agricultural enterprise, that provides grain, food, and energy resources to businesses and consumers. Its Energy segment produces and provides wholesale distribution of petroleum products and transportation of those products. Its Ag segment, which is the key revenue driver, purchases and processes or resells grains and oilseeds; serves as a wholesaler and retailer of crop inputs; produces and markets ethanol. Its Nitrogen Production segment consists of equity method investment in CF Nitrogen, which entitles the purchase of up to a specified quantity of granular urea and UAN annually from CF Nitrogen. Geographically, the company derives maximum revenue from North America and the rest from South America, Asia Pacific, Europe, Middle East, and Africa (EMEA).